Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Oxaliplatin in Treating Patients With Liver Cancer [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of combining sirolimus with bevacizumab in patients with unresectable liver…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 2]
Phase 2 trial update evaluating Cediranib in adults with locally advanced or metastatic hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
A completed Phase 2 clinical trial funded by the National Cancer Institute evaluated the proteasome inhibitor bortezomib for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer [Phase 2]
Phase 2 study evaluating Erlotinib in adults with unresectable hepatocellular carcinoma, cholangiocarcinoma, or gallbladder cancer has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib [Phase 1]
This Phase 1 study assessed how a high-fat versus low-fat breakfast affects regorafenib pharmacokinetics; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery [Phase 2]
A Phase 2 trial evaluated the combination of bevacizumab and erlotinib for unresectable hepatocellular carcinoma to assess efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer [NA]
This clinical trial evaluated PET imaging with carbon-11 acetate and fluorodeoxyglucose F-18 for detecting hepatocellular carcinoma in patie…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Tumor Growth Factors in Hepatocellular Carcinoma
This completed clinical trial investigated tumor growth factors in hepatocellular carcinoma. The study was sponsored by Kaohsiung Medical Un…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma [NA]
This clinical trial update describes associations of interleukin-1B and TNF-α gene polymorphisms with HBV-related hepatocellular carcinoma a…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
A terminated clinical trial evaluated whether Sorafenib or Regorafenib affects P63 expression and keratinocyte differentiation in human skin…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma [Phase 1]
Phase 1 study assessing the combination of RAD001 (everolimus) and sorafenib in patients with advanced hepatocellular carcinoma has been ter…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 [Phase 2]
Phase 2 study evaluating AMT2003 in patients with advanced hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas [Phase 2]
Phase 2 clinical trial evaluating photodynamic therapy for cancers of the bile duct, gallbladder, liver, and pancreas; the study has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy [Phase 2]
This is a completed Phase 2 trial evaluating tivantinib (ARQ 197) in patients with unresectable hepatocellular carcinoma after failure of on…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
Phase 2 trial evaluating gefitinib in adults with advanced unresectable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer [Phase 1]
Phase 1 study assessing the safety of combining sorafenib tosylate with chemoembolization in patients with unresectable hepatocellular carci…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Use of N-Acetylcysteine During Liver Procurement [Phase 2]
This ClinicalTrials.gov entry reports the completion of a Phase 2 study evaluating the use of N-acetylcysteine during liver procurement.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [Phase 2]
Phase 2 trial of thalidomide in combination with interferon alfa in patients with unresectable progressive liver cancer (hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without sargramostim in patients with advanced or metastatic cancer; the study was complete…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction [Phase 1]
Phase 1 study evaluating Erlotinib in adults with unresectable hepatocellular carcinoma and liver dysfunction has completed, reporting initi…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed [Phase 2]
A Phase 2 clinical trial evaluating Sho-Saiko-To for unresectable hepatocellular carcinoma treated with embolization has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: TK-based Suicide Gene Therapy for Hepatocellular Carcinoma [Phase 1]
Phase 1 study of a thymidine kinase–based suicide gene therapy for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [Phase 1]
Phase 1 clinical trial evaluating erlotinib in patients with solid tumors and liver or kidney dysfunction has been completed.